Cell and Gene Therapies
SESSION 12. Cell and Gene Therapies
Cell and gene therapies are revolutionising the treatment paradigms for genetic disorders, malignancies, and rare ailments. The latest breakthroughs in gene editing technologies, notably CRISPR, and their potential to provide cures for conditions previously deemed untreatable will be highlighted. Additionally, the regulatory and ethical quandaries that accompany these pioneering therapies will be examined.
Sub-Sessions:
Track 12-1 CRISPR and Gene Editing Technologies
Track 12-2 Stem Cell Therapies
Track 12-3 Regulatory Landscape for Gene Therapies
Track 12-4 Ethical Considerations in Gene Editing
Track 12-5 Patient Access and Affordability